Login
← Go Back
Windlas Biotech
WINDLAS · Pharma > Pharmaceuticals & Drugs · Chairman: Vivek Dhariwal · MD: Hitesh Windlass · Listing date: Aug. 17, 2021 · Employees: 1028 · Gurugram · http://windlasbiotech.com
Stock Price vs Company Growth
1d
10.7%
1w
15.7%
1m
19.8%
3m
6.5%
6m
7.4%
1y
104.6%
all
31.3%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowJun20Mar21Dec21Sep22Jun23Mar24Latest
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,070 10.7%
667
1,128
Company Overview
Sales
728 Cr
Growth: 19.6%
Profit after Tax
61.7 Cr
Growth: 0.8%
Small Cap
2,244 Cr
P/E: 36.4x
Industry P/E: 29.6x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals
Sales (Cr) ₹ 728
Growth 19.6%
EBITDA 12.4%
P/S 3.1x
Dividend 0.6%
P/E 36.4x
Book Value ₹ 236
PEG Ratio 1.9x
ROE 13.1%
P/B 4.5x
Shareholding Pattern
Institutions
Created with Highcharts 8.2.2Sep22Jun23
Promoters
Created with Highcharts 8.2.2Sep22Jun23
Others
Created with Highcharts 8.2.2Sep22Jun23
Increase    Decrease    No change
Company Profile Detailed
The company provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world. Awards, accreditations and recognitions2018: The company was awarded the TV100 Industrial Excellence Award in the field of medicine.
Belongs to (4 Indices)
Investors (3)
jainam.b...
ajay.kum...
samrocks...
Followers (1)
varsha96